The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.
Within bacterial cells, specialized immune systems known as retrons fend off viral attacks. But that's not all they can do.
In an early phase trial, gene therapy showed an ability to restore function to rods and cones as well as functional vision ...
Astrocytes in the brain exhibit significant regional diversity, but the mechanisms controlling their heterogeneity remain ...
The agency’s inertia and bureaucratic roadblocks are throttling hope for millions of patients. A new center of excellence would provide a solution.
The liver function in post-cardiac arrest brain injury is not known and was investigated in a pig model of global cerebral ...
Global Restriction Endonucleases Market is valued approximately at USD 401.1 million in 2023 and is anticipated to grow with a healthy growth rate of more than 6.60% over the forecast period 2024-2032 ...
BRIDGEWATER, NJ and LONDON, UK / ACCESSWIRE / September 16, 2024 /Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of thera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback